Current Issue

View Larger Image

Past Issues Adlink Subscription Visit Our Publisher

ADVERTISEMENT



Top Keywords




GEN News Highlights: Back to Item

New Target and FDA-Approved Cholesterol-Lowering Drug Identified for HCV Therapy

NPC1L1 is required for HCV to gain entry into cells; NPC1L1-inhibitor ezetimibe delays infection in mouse models.



Click here to log in or to register for free.

You will be taken back to your selected item after log-in/registration.

ADVERTISEMENT

ADVERTISEMENT

ADVERTISEMENT

GENpoll

Funding Early-Stage Companies

How much do you think newly established funds will succeed in helping startups?

Suggest a Poll